Effects of intrathecal MSC-derived neural progenitors (MSC-NP) treatment on biomarker levels in the CSF in patients with progressive multiple sclerosis

John Tuddenham, Violaine Harris, Saud Sadiq Presented at the 68th annual meeting of the American Academy of Neurology, held April 15-21, 2016 in Vancouver, BC, Canada.

Abstract Date

October 17, 2016

Abstracts archive


Tisch MS Research Center of New York

521 West 57th Street
4th Floor
New York, NY 10019
(646) 557-3900

Privacy Policy


Support Tisch MS

Support Tisch MS and our innovative research leading to treatments that improve the lives of patients.